Trial intelligence / Profile preview

PROOF: GnRHa for Fertility Preservation in Oncology Patients

NCT00380406Phase 3Completed

Sponsor
Ottawa Hospital Research Institute
Start
Jan 2007
Primary completion
Jan 2010
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of leuprolide in primary ovarian insufficiency (POI), sponsored by Ottawa Hospital Research Institute. Started Jan 2007; status: completed.

02

Drugs

leuprolide
03

Conditions

primary ovarian insufficiency (POI)

Beyond the preview

Go deeper on NCT00380406.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00380406.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call